---
title: CRO Daily News — October 29, 2026
slug: daily-news-2026-10-29-cro
site: cro
post_kind: news
byline: BioBM
description: October 29 CRO daily: PSI CRO and Appian Launch AI-Driven Clinical Trial Site Selection Platform; Viedoc and Bioforum Enhance Clinical Data Integration with…
canonical_url: https://www.cro.directory/posts/daily-news-2026-10-29-cro
published_at: 2026-10-29T23:59:46.630Z
last_updated: 2026-10-30T00:03:26.616Z
---

### PSI CRO and [Appian](/companies/appian) Launch AI-Driven Clinical Trial Site Selection Platform
- PSI CRO has partnered with [Appian](/companies/appian) to create an AI-powered platform for automating clinical trial site selection.
- The solution aims to enhance site selection accuracy and reduce patient recruitment delays by integrating AI with existing systems.

**Operational Impact**

This collaboration allows [PSI](/companies/appian) CRO to improve site selection processes, potentially increasing trial enrollment rates across various therapeutic areas and geographies.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cro-news/psi-cro-partners-with-appian-to-deploy-ai-powered-clinical-trial-site-selection-platform)*

---

### [Viedoc](/companies/viedoc) and [Bioforum](/companies/bioforum) Enhance Clinical Data Integration with New Partnership
- [Viedoc](/companies/viedoc) and [Bioforum](/companies/bioforum) formalize a partnership to integrate Viedoc EDC with BioGRID, enhancing clinical data review processes.
- The collaboration aims to provide study teams with a comprehensive view of clinical data, improving decision-making and analytics.

**Operational Impact**

This integration allows [Bioforum](/companies/bioforum)'s BioGRID platform to utilize data from [Viedoc](/companies/viedoc) EDC, improving the workflow for clinical data review and analytics.

*Source: [PR Newswire pharma category RSS](https://www.prnewswire.com/news-releases/viedoc-and-bioforum-partner-as-biogrid-joins-the-viedoc-verified-technology-partner-program-302923697.html)*

---

### ProtaGene Appoints Matthias Bucerius as CEO to Enhance Analytical Services for Biologics
- ProtaGene has appointed Matthias Bucerius, PhD, as CEO to strengthen its regulatory-ready analytical services for biologics and advanced therapies.
- Bucerius brings extensive experience from Merck KGaA, where he oversaw drug substance manufacturing sites and FDA inspections.

**Operational Impact**

Bucerius's leadership is expected to improve data quality and project delivery across ProtaGene's four sites in Europe and North America.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cro-news/protagene-appoints-former-merck-kgaa-cdmo-executive-matthias-bucerius-as-ceo)*

## References

1. [PharmaSource RSS — PSI CRO and Appian Launch AI-Driven Clinical Trial Site Selection Platform](https://pharmasource.global/content/news/cro-news/psi-cro-partners-with-appian-to-deploy-ai-powered-clinical-trial-site-selection-platform)
2. [PR Newswire pharma category RSS — Viedoc and Bioforum Enhance Clinical Data Integration with New Partnership](https://www.prnewswire.com/news-releases/viedoc-and-bioforum-partner-as-biogrid-joins-the-viedoc-verified-technology-partner-program-302923697.html)
3. [PharmaSource RSS — ProtaGene Appoints Matthias Bucerius as CEO to Enhance Analytical Services for Biologics](https://pharmasource.global/content/news/cro-news/protagene-appoints-former-merck-kgaa-cdmo-executive-matthias-bucerius-as-ceo)

Source: https://www.cro.directory/posts/daily-news-2026-10-29-cro